Health

EMA Backs Preventive Therapy for Stage 3 Type 1 Diabetes

TribeNews
By TribeNews 2 Views Add a Comment
0 Min Read
EMA Backs Preventive Therapy for Stage 3 Type 1 Diabetes

The European Medicines Agency (EMA) has recommended granting marketing authorization for Teizeild (teplizumab) to delay the onset of stage 3 type 1 diabetes (T1D) in patients aged 8 years and older with stage 2 T1D.  Teizeild was granted entry into the PRIME medicine scheme in 2019…

Leave a Comment
Ads Blocker Image Powered by Code Help Pro

Ads Blocker Detected & This Is Prohibited!!!

We have detected that you are using extensions to block ads and you are also not using our official app. Your Account Have been Flagged and reported, pending de-activation & All your earning will be wiped out. Please turn off the software to continue

You cannot copy content of this app